Process for producing a preparation in powder form containing at least one carotenoid
US-2016338964-A1 · Nov 24, 2016 · US
US10709152B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10709152-B2 |
| Application number | US-201816050012-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 31, 2018 |
| Priority date | Apr 22, 2016 |
| Publication date | Jul 14, 2020 |
| Grant date | Jul 14, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to a new alga having an improved ability to produce a pigment, and when a mutant of the present invention is used, a carotenoid-based pigment, specifically, a xanthophyll can be produced by consuming less energy, so that it is possible to efficiently produce the pigment at the industrial level. Further, the pigment can be applied as a raw material for a food, a health functional food and a medicine, which include the pigment. In particular, since a DNA fragment is not likely to be inserted into a target base sequence or a base sequence other than the target, it is expected that the procedure of constructing the mutant is not regulated as a GMO, so that it is expected that the procedure of constructing the mutant can create a big economic effect in terms of an industry which produces lutein and zeaxanthin by using microalgae.
Opening claim text (preview).
The invention claimed is: 1. A Chlamydomonas reinhardtii mutant having a ZEP gene mutation in which a base sequence represented by SEQ ID No. 2 is inserted between a 816th base and a 817th base in a ZEP gene sequence of a Chlamydomonas reinhardtii represented by SEQ ID No. 1 and having an ability to produce a xanthophyll. 2. The Chlamydomonas reinhardtii mutant of claim 1 , wherein the Chlamydomonas reinhardtii mutant has a ZEP gene mutation represented by SEQ ID No. 3. 3. The Chlamydomonas reinhardtii mutant of claim 1 , wherein the mutant has an ability to produce one or more pigments selected from a group consisting of lutein and zeaxanthin; and chlorophyll b, chlorophyll a, and β-carotene. 4. A composition for oral administration comprising one or more selected from a group consisting of a culture of the mutant of claim 1 , a dry material thereof, and an extract thereof.
Algae {; Processes using algae} · CPC title
Unicellular algae isolates · CPC title
with reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen (1.14.15) · CPC title
Zeaxanthin epoxidase (1.14.13.90) · CPC title
Unicellular algae; Culture media therefor (as new plants A01H13/00) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.